logo

Pfizer & BioNTech phase 3 COVID-19 vaccine trials resume in SA

Pfizer and BioNTech have started its enrolment of participants in South Africa for its phase 3 COVID-19 vaccine trials.


Thu Oct 01 2020 | 11:18:03 GMT+0000 (Coordinated Universal Time)

Share

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.